C21 Investments Reports First Quarter Results
New Dispensary Operational at the End of Q1
First Quarter Highlights (
- Revenue of
$6.6 million , up 1% from Q4 – state ofNevada sales down 1% over the comparative period[1] - Gross Margin of 31%, impacted by temporary internal inventory supply issues and resulting product mix with the launch of the
South Reno dispensary (see management commentary below and in MD&A) - Earnings (Loss) Per Share of (
$0.01 ) - Cash Flow from Operations of
$0.6 million ; positive Free Cash Flow[2] of$0.4 million - Acquisition of 3rd dispensary closed in the quarter (see news release dated
June 10, 2024 ); new dispensary rebranded and operational during final week of Q1 - Closed
C$4.0 million convertible debenture financing, principal funding for the acquisition of the new dispensary (see news release datedMay 6, 2024 )
_____________________________ |
2 Refer to "Non-GAAP Measures" disclosure at the end of this news release for a description and calculation of this measure |
3
|
"Our Company reported a slight increase in revenue over Q4 (ended
Q1 revenue of
Q1 did not include material results from the new Silver State Relief dispensary, which opened
Gross Margin of 31% was down in Q1 resulting from several factors (see MD&A) including one-time internal inventory supply issues, delays in approvals for production upgrades, and continued retail price discounting in the state.
SG&A was impacted by non-capitalized start-up costs for the new dispensary, as well as non-cash share-based compensation, the first grant of employee options since 2020.
Cash Flow from Operations was
C21 reported a Net Loss of
Cash at the end of Q1 was relatively flat from the stub period at
As C21 operates in the cannabis industry, the Company is subject to the limitations of Internal Revenue Code ("IRC") Section 280E for US income tax purposes. Under 280E, the Company is only allowed to deduct expenses for tax purposes directly related to costs of goods sold. Given the recent announcement by the D.E.A. to reclassify cannabis as a Schedule III drug, C21 anticipates the elimination of the future applicability of IRC Section 280E on its business upon final rule. Many
Non-GAAP Measures:
C21 reports its financial results in accordance with GAAP and uses a number of financial measures when assessing its results and measuring overall performance. Some of these financial measures and ratios are not calculated in accordance with GAAP. The Company refers to certain Non-GAAP financial measures such as "Free Cash Flow", "Adjusted EBITDA" and "same store sales". These measures do not have any standardized meanings prescribed by GAAP and may not be comparable to similar measures presented by other issuers. The Company considers these measures to be an important indicator of the financial strength and performance of its business. The Company believes the adjusted results presented provide relevant and useful information for investors because they clarify the Company's actual operating performance, make it easier to compare the Company's results with those of other companies and allow investors to review performance in the same way as the management of the Company. Since these measures are not calculated in accordance with GAAP, they should not be considered in isolation of, or as a substitute for, the Company's reported results as indicators of the Company's performance, and they may not be comparable to similarly named measures from other companies. The tables below provide reconciliations of Non-GAAP financial measures to the most directly comparable GAAP measures.
"Free Cash Flow" is defined as Cash Provided by Operating Activities from Continuing Operations in a period minus capital expenses of property and equipment. Management believes that Free Cash Flow, which measures the Company's ability to generate additional cash from our continuing business operations, is an important financial measure for use in evaluating the Company's financial performance. Free Cash Flow should be considered in addition to, rather than as a substitute for, consolidated net income as a measure of the Company's performance and net cash provided by operating activities as a measure of liquidity.
Free Cash Flow:
|
Q1 |
Two Month Stub |
Q4 |
Q3 |
Q2 |
Quarter Ended |
|
|
|
|
|
Cash Provided by Operating Activities OCF Margin% |
$ 588,478 |
$ 904,620 |
$ 506,477 |
$ (110,329) |
$ 1,649,786 |
Purchase of Property and Equipment |
(169,660) |
(51,483) |
(7,240) |
(259,343) |
(202,182) |
Free Cash Flow |
$ 418,818 |
$ 853,137 |
$ 499,237 |
$ (369,372) |
$ 1,447,604 |
"Adjusted EBITDA" is defined as EBITDA (earnings before depreciation and amortization, depreciation and interest in cost of sales, income taxes, and interest) less accretion, loss from discontinued operations, one-time transaction costs and all other non-cash items. The Company has presented "Adjusted EBITDA" because its management believes it is a useful measure for investors when assessing and considering the Company's continuing operations and prospects for the future. Furthermore, "Adjusted EBITDA" is a commonly used measurement in the financial community when evaluating the market value of similar companies.
Adjusted EBITDA:
|
Q1 |
Two Month Stub |
Q4 |
Q3 |
Q2 |
|
||||||||
|
|
|
|
|
|
|
||||||||
Net Income (Loss) |
$ (1,412,172) |
$ (74,404) |
$ (2,042,004) |
$ (376,150) |
$ (416,086) |
|
||||||||
|
|
|
|
|
|
|
||||||||
Interest expenses, net |
136,752 |
- |
- |
- |
3,956 |
|
||||||||
Provision for Income Taxes |
367,700 |
372,743 |
1,723,925 |
563,100 |
602,674 |
|
||||||||
Depreciation and Amortization |
379,522 |
207,225 |
359,568 |
355,536 |
346,294 |
|
||||||||
Depreciation and Interest in |
203,091 |
135,395 |
203,092 |
203,092 |
203,092 |
|
||||||||
EBITDA |
(325,107) |
632,526 |
$ 244,581 |
$ 745,578 |
$ 739,930 |
|
||||||||
Change in fair value of derivative |
- |
(22,189) |
59,217 |
- |
- |
|
||||||||
Share based compensation |
422,218 |
- |
5,527 |
5,499 |
5,595 |
|
||||||||
Loss from discontinued |
25,724 |
22,965 |
(40,357) |
18,932 |
19,351 |
|
||||||||
One-time special project costs |
117,543 |
- |
- |
159,000 |
- |
|
||||||||
Production curtailment, non- |
28,700 |
- |
- |
- |
206,000 |
|
||||||||
Other gain/loss |
41,740 |
(9,209) |
785,763 |
13,800 |
921 |
|
||||||||
Adjusted EBITDA |
310,818 |
632,526 |
$ 1,054,731 |
$ 942,809 |
$ 971,797 |
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q1 Balance Sheet Summary:
(US$) |
|
|
|
|||
Assets |
|
|
|
|||
Cash |
3,107,507 |
3,260,568 |
|
|||
Inventory |
3,300,346 |
2,866,054 |
|
|||
Other current |
1,897,852 |
2,011,700 |
|
|||
Current Assets |
8,305,705 |
8,138,322 |
|
|||
Fixed Assets/ |
50,013,169 |
47,087,514 |
|
|||
Total Assets |
58,318,874 |
55,225,836 |
|
|||
|
|
|
|
|||
Liabilities |
|
|
|
|||
Accounts payable |
3,388,654 |
2,593,195 |
|
|||
Income taxes payable |
10,598,123 |
10,230,423 |
|
|||
Convertible Debentures (current portion) |
497,300 |
- |
|
|||
Other notes, current lease, deferred tax etc. |
2,238,047 |
2,223,539 |
|
|||
Current Liabilities |
16,722,124 |
15,047,157 |
|
|||
Lease liabilities |
9,009,837 |
9,120,396 |
|
|||
Convertible Debentures |
1,542,379 |
- |
|
|||
Derivative liability and other |
84,021 |
84,871 |
|
|||
Total Liabilities |
27,358,361 |
24,252,424 |
|
|||
|
|
|
|
|||
Shareholders' Equity |
30,960,513 |
30,973,412 |
|
|||
Total Liabilities and Shareholders' Equity |
58,318,874 |
55,225,836 |
|
Q1 Summary Income Statement:
|
Q1 |
Two Month Stub |
Q4 |
(US$) |
|
|
|
Revenue |
6,596,009 |
4,464,950 |
6,548,812 |
Cost of Sales |
4,565,310 |
2,688,650 |
3,702,469 |
Gross Profit |
2,030,699 |
1,776,300 |
2,846,343 |
Gross Margin% |
30.8 % |
39.8 % |
43.5 % |
Total Expenses |
2,870,955 |
1,486,394 |
2,317,335 |
Income from Operations |
(840,256) |
289,906 |
529,008 |
Income Tax Expense |
(367,700) |
(372,304) |
(1,723,925) |
Net Income (Loss) |
(1,412,172) |
(74,404) |
(1,209,694) |
Earnings (Loss) Per Share |
(0.01) |
(0.00) |
(0.01) |
About
Cautionary Note Regarding Forward-Looking Information and Statements:
This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may constitute "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 (collectively, "Forward-Looking Statements"). Forward-Looking Statements in this news release include but are not limited to: the Company's belief that its change in fiscal year end will better align the Company with the reporting schedule of its peers and better equip our auditors to complete their work in a timely manner moving forward; the Company's focus on ramping its new store and continuing to pursue additional opportunities in the market; and improving margins in the second half of the year. Such Forward-Looking Statements represent the Company's beliefs and expectations regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control.
Forward-Looking Statements are based on assumptions, estimates, analyses and opinions of management of the Company at the time they were provided or made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including: achieving the anticipated results of the Company's strategic plans; and general economic, financial market, regulatory and political conditions in which the Company operates.
A variety of factors, including known and unknown risks, many of which are beyond the Company's control, could cause actual results to differ materially from the Forward-Looking Statements in this news release. Such factors include, without limitation: risks and uncertainties arising from: the inability to effectively manage growth; inputs, suppliers and skilled labour being unavailable or available only at uneconomic costs; the adequacy of the Company's capital resources and liquidity, including but not limited to, availability of sufficient cash flow to execute the Company's business plan (either within the expected timeframe or at all); changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws generally and adverse future legislative and regulatory developments involving medical and recreational marijuana; the risks of operating in the marijuana industry in
Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the Forward-Looking Statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such Forward-Looking Statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. Should assumptions underlying the Forward-Looking Statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
The Forward-Looking Statements contained in this news release are made as of the date of this news release, and the Company does not undertake to update any Forward-Looking Statements that are contained or referenced herein, except in accordance with applicable securities laws.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE